Cargando…

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma

BACKGROUND: Choline presents a high affinity for malignant prostate tissue. It can be labelled with positron emitting (18)F, and used for the evaluation of patients with prostate carcinoma by PET/CT imaging. The aim of this paper is to summarise our experience with fluoromethylcholine ((18)F-choline...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hodolic, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita, Warsaw 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423714/ https://www.ncbi.nlm.nih.gov/pubmed/22933929 http://dx.doi.org/10.2478/v10019-010-0050-8

Ejemplares similares

(18)F-FET and (18)F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study
por: Mišir Krpan, Ana, et al.
Publicado: (2021)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
por: Olivari, Laura, et al.
Publicado: (2020)

Imaging Comparison between (18)F-FDG-PET/CT and (18)F-Flouroethyl Choline PET/CT in Rare Case of Thymus Carcinoma Exhibiting a Positive Choline Uptake
por: Takesh, Mustafa, et al.
Publicado: (2013)

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
por: Wang, Rang, et al.
Publicado: (2021)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and (18) F-choline PET/CT
por: Vees, Hansjörg, et al.
Publicado: (2012)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020)

Head-to-Head Comparison of [(18)F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [(18)F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer
por: García-Zoghby, Laura, et al.
Publicado: (2023)

New Acquisition Protocol of (18)F-Choline PET/CT in Prostate Cancer Patients: Review of the Literature about Methodology and Proposal of Standardization
por: Chondrogiannis, Sotirios, et al.
Publicado: (2014)

[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
por: Pasqualetti, Francesco, et al.
Publicado: (2016)

PET/CT with (18)F-choline or (18)F-FDG in Hepatocellular Carcinoma Submitted to (90)Y-TARE: A Real-World Study
por: Filippi, Luca, et al.
Publicado: (2022)

Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
por: Sollini, Martina, et al.
Publicado: (2016)

The Added Value of [(18)F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report
por: Piras, Antonio, et al.
Publicado: (2022)

Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using (11)C-Choline and (18)F-FDG PET/CT
por: Jiang, Jun, et al.
Publicado: (2015)

Accuracy of tumor segmentation from multi-parametric prostate MRI and (18)F-choline PET/CT for focal prostate cancer therapy applications
por: Piert, Morand, et al.
Publicado: (2018)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy
por: Hodolic, Marina, et al.
Publicado: (2016)

An Incidental Pancreatic Finding at 18F-Choline PET/CT: Chronic Mass-Forming Pancreatitis
por: Evangelista, Laura, et al.
Publicado: (2021)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

The Role of [(18)F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach
por: Urso, Luca, et al.
Publicado: (2022)

Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [(18)F] Choline PET/MRI
por: Wetter, Axel, et al.
Publicado: (2014)

PET/CT analysis of 21 patients with breast cancer: physiological distribution of (18)F-choline and diagnostic pitfalls
por: Ahmad Saad, Fathinul Fikri, et al.
Publicado: (2018)

[(18)F]DCFPyL PET/CT versus [(18)F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
por: Oprea-Lager, Daniela-Elena, et al.
Publicado: (2023)

An Incidental Renal Oncocytoma: (18)F-Choline PET/MRI
por: Mallia, Andrew, et al.
Publicado: (2016)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

Predictive factors of (18)F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?
por: Johnson, Alison C., et al.
Publicado: (2016)

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
por: Pinkawa, Michael, et al.
Publicado: (2012)

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
por: Huysse, Wouter, et al.
Publicado: (2017)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase α
por: Grech-Sollars, Matthew, et al.
Publicado: (2019)

(11)C-choline vs. (18)F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
por: Nanni, Cristina, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_qs9uqct3p7eu8c1kak4bdhg7i8